Shegog Todd
- SEC CIK
- 0001714564
No open-market purchases or sales filed in the past year.
Current role at each company
- COGT Cogent Biosciences, Inc.Directoras of Jun 11, 2026
- FMTX Forma Therapeutics Holdings, Inc.SVP, Chief Financial Officeras of Oct 14, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Shegog Todd as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
FMTX Forma Therapeutics Holdings, Inc.
SVP, Chief Financial Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 25, 2022 (view filing) | Feb 23 | 2 days | Shegog ToddSVP, Chief Financial Officer | SSale | −5.69K | $9.78 | −$55.6K | −20.0%22.8K after |